Small Animal Imaging In Vivo Market Regional Analysis

Global Small Animal Imaging In Vivo Market size was valued at USD 1.07 billion in 2023 and is poised to grow from USD 1.15 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032). 

Major manufacturers are focusing on executing crucial business tactics like collaboration, acquisition, and new product releases in order to increase their product line and keep a monopoly on the market. In the numerous submarkets of the global small animal imaging market, there are a number of regional and international players. Most market participants want to increase their market share, therefore innovation is being included into both their products and acquisitions. 'Bruker Corporation (US) ', 'PerkinElmer, Inc. (US) ', 'FUJIFILM Holdings Corporation (Japan) ', 'Siemens Healthineers AG (Germany) ', 'Miltenyi Biotec (Germany) ', 'Aspect Imaging (Israel) ', 'Thermo Fisher Scientific Inc. (US) ', 'GE Healthcare (US) ', 'Mediso Ltd. (Hungary) ', 'MR Solutions Ltd. (UK) ', 'TriFoil Imaging (US) ', 'LI-COR Biosciences (US) ', 'Agilent Technologies, Inc. (US) ', 'Hitachi Ltd. (Japan) ', 'Canon Medical Systems Corporation (Japan) ', 'In March 2021, Real-time reverse transcription (qRT) PCR-based diagnostic kit for SARS-CoV-2 RNA detection will be released, according to Agilent Technologies Inc., an American analytical equipment development and manufacturing firm that provides its goods and services to markets across the world.', 'In April 2021, After getting regulatory permission from the Competition Commission of India, Siemens AG, one of the major players in the global small animal imaging market, bought C&S Electric, an Indian maker of grid technology, for about $285 million, acquiring roughly 99.22 percent of the business.'

Growing adoption of multimodal imaging equipment is expected to grow the market during the forecasted period. Moreover, the expansion of the small animal (in-vivo) imaging market will be aided by the rising costs for the healthcare industry.

The rapid increase in demand for non-invasive small animal imaging techniques is a key factor in the market's expansion. Other important factors include the expansion of pharmaceutical companies and research organisations, the funding of various developments made by both public and private organisations, and the rapid advancement of many fields, including chemistry, computer science, engineering, medicine, and molecular biology. Additionally, the small animal imaging (in-vivo) market will see new growth prospects during the predicted period of 2021–2028 due to an increase in demand from emerging nations and an increase in market R&D efforts.

North America contributed the most to global revenue. The expansion of the market in the area can be ascribed to the development of inventive modality as a result of technical progress. The industry is expected to have great growth throughout the forecast period thanks to a variety of preclinical research being conducted in the area.